Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q4 Loss of $0.59

March 27, 2013 4:02 PM EDT Send to a Friend

Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) reported ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Q4 Loss of $0.59

Member Login

Free News Feed